Clinical Trial Update: Alflutinib Versus Alflutinib Plus Chemotherapy for NSCLC [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial comparing alflutinib alone versus alflutinib with chemotherapy in non-small cell lung cancer (NSCLC) across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Alflutinib (alflutinib)

Snippet

Sponsor: The First Affiliated Hospital of Henan University of Science and Technology | Conditions: NSCLC | Phase 2, Phase 3 | Status: UNKNOWN